Items where authors include "Bell, S."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Bell, S. and Hindmoor, A. orcid.org/0000-0002-0335-2509 (2024) Rethinking the theory of quiet politics: bad corporate behaviour and the failure of quiet politics in the east coast gas crisis in Australia, 2022. Business and Politics, 26 (4). ISSN 1369-5258

Alqurashi, N. orcid.org/0000-0003-4417-4128, Bell, S. orcid.org/0000-0003-3891-6623, Carley, S.D. et al. (2 more authors) (2024) Head injury evaluation and ambulance diagnosis (HOME) study protocol: a feasibility study assessing the implementation of the Canadian CT Head Rule in the prehospital setting. BMJ Open, 14 (6). e077191. ISSN 2044-6055

Bretherton, C.P. orcid.org/0000-0001-9569-0734, Hirst, R., Gacaferi, H. et al. (21 more authors) (2024) Research priorities for the management of major trauma: an international priority setting partnership with the James Lind Alliance. BMJ Open, 14 (5). e083450. ISSN 2044-6055

Holmes, E. orcid.org/0000-0002-0479-5336, Dixon, P. orcid.org/0000-0002-2150-5580, Mathieson, A. orcid.org/0000-0002-5360-3644 et al. (12 more authors) (2024) Developing an alternative care pathway for emergency ambulance responses for adults with epilepsy: A Discrete Choice Experiment to understand which configuration service users prefer. Part of the COLLABORATE project. Seizure: European Journal of Epilepsy, 118. pp. 28-37. ISSN 1059-1311

Bell, S. and Hindmoor, A. orcid.org/0000-0002-0335-2509 (2024) Business politics is usually about attempts to exert influence rather than power. Business and Politics, 26 (1). ISSN 1469-3569

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Bell, S., Hindmoor, A. orcid.org/0000-0002-0335-2509 and Umashev, N. (2023) The determinants of corporate political activity in Australia. Australian Journal of Political Science, 58 (4). pp. 363-382. ISSN 1036-1146

Basu, B. orcid.org/0000-0002-5434-5202, Lake, A.V.R. orcid.org/0000-0002-6341-8661, China, B. et al. (6 more authors) (2023) Racgap1 knockdown results in cells with multiple cilia due to cytokinesis failure. Annals of Human Genetics. ISSN 0003-4800

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Alqurashi, N., Alotaibi, A. orcid.org/0000-0002-6465-2687, Bell, S. et al. (2 more authors) (2023) Towards exploring current challenges and future opportunities relating to the prehospital triage of patients with traumatic brain injury: a mixed-methods study protocol. BMJ Open, 13. e068555. ISSN 2044-6055

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

Alqurashi, N., Alotaibi, A., Bell, S. et al. (2 more authors) (2022) The diagnostic accuracy of prehospital triage tools in identifying patients with traumatic brain injury: a systematic review. Injury, 53 (6). pp. 2060-2068. ISSN 0020-1383

Coen, O., Corrie, P., Marshall, H. et al. (17 more authors) (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC Cancer, 21 (1). 761. ISSN 1471-2407

Danson, S. orcid.org/0000-0002-3593-2890, Hook, J., Marshall, H. et al. (4 more authors) (2019) Are we over-treating with checkpoint inhibitors? British Journal of Cancer, 121 (8). pp. 629-630. ISSN 0007-0920

Drake, T.M., Cheung, L.K., Gaba, F. et al. (98 more authors) (2018) Association between peri-operative angiotensin-converting enzyme inhibitors and angiotensin-2 receptor blockers and acute kidney injury in major elective non-cardiac surgery: a multicentre, prospective cohort study. Anaesthesia, 73 (10). pp. 1214-1222. ISSN 0003-2409

Astbury, J. orcid.org/0000-0002-0334-9465 and Bell, S. (2018) Assessing and addressing energy vulnerability at the community scale: an interpretive case study. People, Place and Policy Online, 12 (1). pp. 29-46. ISSN 1753-8041

Bell, S. and Hindmoor, A. (2017) Are the major global banks now safer? Structural continuities and change in banking and finance since the 2008 crisis. Review of International Political Economy, 25 (1). pp. 1-27. ISSN 0969-2290

Bell, S. and Hindmoor, A. (2017) Structural Power and the Politics of Bank Capital Regulation in the UK. Political Studies, 65 (1). pp. 103-121. ISSN 0032-3217

Mason, H., van Exel, J., Baker, R. et al. (33 more authors) (2016) From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries. Social Science and Medicine, 166. pp. 205-213. ISSN 0277-9536

Proceedings Paper

Rawstron, A., Webster, N., Dalal, S. et al. (15 more authors) (2023) Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. In: Blood. 65th ASH: Annual Meeting & Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , p. 632.

Bell, S., De Marco, M., Barnes, K. et al. (5 more authors) (2020) Do deficits in mitochondrial spare respiratory capacity contribute to neuropsychological changes seen in Alzheimer's disease? In: Neurology. UNSPECIFIED. Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology .